NJ Drug Co. Dodges Class Action Over FDA Approval Claims
A New Jersey federal judge on Friday tossed a proposed securities class action against Eagle Pharmaceuticals Inc., saying investors have failed to back up their claims that the company made false...To view the full article, register now.
Already a subscriber? Click here to view full article